PAVmed (PAVM) Net Cash Flow Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -562.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -564.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 76.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -31.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -394.13% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 57.36% |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | -461.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -461.90% |
| Jun 30, 2025 | 3,564.86% |
| Mar 31, 2025 | -74.63% |
| Dec 31, 2024 | 106.20% |
| Jun 30, 2024 | 99.69% |
| Mar 31, 2024 | -38.16% |
| Dec 31, 2023 | 60.28% |
| Sep 30, 2023 | -28.53% |
| Jun 30, 2023 | -3,012.74% |
| Mar 31, 2023 | 176.16% |
| Dec 31, 2022 | -142.69% |
| Sep 30, 2022 | -42.58% |
| Jun 30, 2022 | 107.80% |
| Mar 31, 2022 | -140.02% |
| Dec 31, 2021 | 345.35% |
| Sep 30, 2021 | -583.84% |
| Jun 30, 2021 | -223.20% |
| Mar 31, 2021 | 1,145.62% |
| Dec 31, 2020 | 322.38% |
| Sep 30, 2020 | 143.15% |
| Jun 30, 2020 | -160.74% |
| Mar 31, 2020 | 162.30% |
| Dec 31, 2019 | 308.16% |
| Sep 30, 2019 | -50.11% |
| Jun 30, 2019 | -63.79% |
| Mar 31, 2019 | -292.40% |
| Dec 31, 2018 | 35.33% |
| Sep 30, 2018 | -161.82% |
| Jun 30, 2018 | 1,011.48% |
| Mar 31, 2018 | 554.95% |
| Dec 31, 2017 | -31.05% |
| Sep 30, 2017 | 345.46% |
| Jun 30, 2017 | 45.39% |
| Mar 31, 2017 | 160.23% |
| Dec 31, 2016 | -85.64% |
| Sep 30, 2016 | -238.10% |
| Jun 30, 2016 | -626.42% |
| Mar 31, 2016 | -383.48% |